Genito-Urinary Drugs Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery

Jun 2020| TBR950B| TBRC (Publisher)

Report Highlights

Including: Hormonal Contraceptives; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Drugs For Erectile Dysfunction; Drugs For Benign Prostatic hypertrophy; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infertility; Diuretics

The global genito-urinary drugs market is expected to decline from $54.1 billion in 2019 to $53.7 billion in 2020 at a CAGR of -0.73%, this is due to disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 outbreak. The market is then expected to recover and grow at a CAGR of 3.74% from 2020 to reach $60.0 billion in 2023.

Genito-Urinary Drugs Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs sector.

Reasons to Purchase

  • Fully updated for 2020 including the impact of the Covid 19/ Novel Coronavirus.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and key trends
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.

Description

Genito-Urinary Drugs Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the genito-urinary drugs market revenues, covering both the historic growth of the market and forecasting the future.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

The trends and strategies section highlights the likely future developments in the genito-urinary drugs market and suggests approaches.

Scope

Markets Covered: Hormonal Contraceptives; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Drugs For Erectile Dysfunction; Drugs For Benign Prostatic hypertrophy; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infertility; Diuretics

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa

Time series: Five years historic and forecast
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report